Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium.
D000328:Adult; D000975:Antioxidants / Q000378:metabolism / Q000627:therapeutic use*; D013956:Antithyroid Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005979:Glutathione Peroxidase / Q000097:blood*; D006111:Graves Disease / Q000188:drug therapy*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D012643:Selenium / Q000097:blood*; D013054:Spectrophotometry, Atomic; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D000975:Antioxidants; D013956:Antithyroid Agents; D006454:Hemoglobins; D014284:Triiodothyronine; D008713:Methimazole; D013972:Thyrotropin; D005979:Glutathione Peroxidase; D012643:Selenium; D013974:Thyroxine